Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Botulinum A Toxin (OnabotulinumtoxinA) Use in Mexican Pediatric Population With Spasticity Associated With Cerebral Palsy: Phase IV, Observational, Non-Interventional, Prospective, Multicenter Study

NCT06150729 is registered in ClinicalTrials.gov with AbbVie as lead sponsor.

NCT NCT06150729
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06150729 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Botulinum A Toxin (OnabotulinumtoxinA) Use in Mexican Pediatric Population With Spasticity Associated With Cerebral Palsy: Phase IV, Observational, Non-Interventional, Prospective, Multicenter Study
Lead sponsor
AbbVie
Phase
Observational
Overall status
Completed
Start date
September 8, 2023
Completion date
May 30, 2025
Enrollment
107 (actual)
Sites
8

Conditions

As the registry lists them; a condition with its own page is linked.

spasticity